Chris French
Director Técnico/Científico/I+D en CHECKMATE PHARMACEUTICALS, INC. .
Perfil
Chris French is currently the Vice President-Scientific Affairs at Checkmate Pharmaceuticals, Inc. She holds a Master's in Business Administration from St. Thomas University (Florida) and an undergraduate degree from the University of Mankato.
Cargos activos de Chris French
| Empresas | Cargo | Inicio |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/07/2016 |
Formación de Chris French.
| University of Mankato | Undergraduate Degree |
| St. Thomas University (Florida) | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Chris French
